Merck and Metabasis Target Metabolic Diseases

By Business Review Editor

Pharma Deals Review: Vol 2005 Issue 62 (Table of Contents)

Published: 5 Aug-2005

DOI: 10.3833/pdr.v2005.i62.643     ISSN: 1756-7874

Section: General

Abstract

Metabasis Therapeutics entered into agreement with Merck & Co...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details